Lv5
910 积分 2022-05-18 加入
MANAGEMENT OF ENDOCRINE DISEASE: Medullary thyroid cancer: from molecular biology and therapeutic pitfalls to future targeted treatment perspectives
1天前
已完结
Progress and challenges in RET-targeted cancer therapy
14天前
已完结
Landscape of Genomic Mechanisms of Resistance to Selective RET Inhibitors in RET-Altered Solid Tumors: Analysis of the RETgistry Global Consortium
16天前
已完结
Subcellular localization of PUMA regulates its pro-apoptotic activity in Burkitt's lymphoma B cells
2个月前
已关闭
RET/PTC Rearrangements in Thyroid Nodules: Studies in Irradiated and Not Irradiated, Malignant and Benign Thyroid Lesions in Children and Adults
2个月前
已关闭
A comprehensive overview of the role of the RET proto-oncogene in thyroid carcinoma
2个月前
已完结
MANAGEMENT OF ENDOCRINE DISEASE: Medullary thyroid cancer: from molecular biology and therapeutic pitfalls to future targeted treatment perspectives
2个月前
已完结
Unraveling the Promise of RET Inhibitors in Precision Cancer Therapy by Targeting RET Mutations
2个月前
已完结
98 (PB086): First-in-human, phase 1 study of a selective RET inhibitor, LOXO-260, in patients with RET inhibitor refractory, RET-altered cancers
2个月前
已关闭
Discovery of APS03118, a Potent and Selective Next-Generation RET Inhibitor with a Novel Kinase Hinge Scaffold
2个月前
已完结
皖公网安备34019202002308
